Avidity Biosciences
RNA
$26.60
Share price
2.15%
Change (1 day)
123.72%
Change (1 year)
Categories
Market capitalization of Avidity Biosciences (RNA)
Market cap: $2.54 Billion
As of June 2024 Avidity Biosciences has a market cap of $2.54 Billion. This makes Avidity Biosciences the world's 3737th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Avidity Biosciences from 2020 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.54 B | 255.03% |
| 2023 | $0.71 B | -51.41% |
| 2022 | $1.47 B | 32.3% |
| 2021 | $1.11 B | 16.4% |
| 2020 | $0.95 B |
End of Day market cap according to different sources
On Jun 8th, 2024 the market cap of Avidity Biosciences was reported to be:
$2.54 Billion
$2.54 Billion
$2.54 Billion
$2.54 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $161.95 B | 6,266.16% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $85.55 B | 3,263.02% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | $11.65 B | 358.21% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $2.80 B | 10.10% | 🇺🇸 USA |
 Fate Therapeutics
FATE | $0.41 B | -83.53% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.82 M | -99.97% | 🇺🇸 USA |
 Acceleron Pharma XLRN | $10.93 B | 329.71% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $1.84 B | -27.48% | 🇺🇸 USA |